{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:40:10Z","timestamp":1784202010738,"version":"3.55.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1S","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>Little is known about how the achievement of sustained virological response (SVR) after treatment with direct-antiviral agents (DAAs) affects fibrosis and clinical outcomes in the long term. Our study aimed to evaluate the impact of achieving SVR on long-term changes in fibrosis and clinical outcomes in CHC patients treated with different DAAs-based regimens.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>a prospective, 3-year follow-up study of 113 CHC patients who had achieved SVR after treatment with different DAAs-based regimens between January and June 2015 was conducted. The clinical outcomes of SVR on the biochemical profile, changes in fibrosis, ALBI score and grade and occurrence of liver-related events were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Overall, liver function parameters and serum alpha-fetoprotein level showed improvement from baseline to SVR12 and remained steady thereafter. Moreover, the ALBI score showed nonsignificant change at baseline to SVR12 (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.2) but it was significantly better at 3-years follow-up than at SVR12 (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.001). Regarding liver stiffness (LS) by transient elastography, a significant decrease in TE values was observed between baseline to SVR12 (<jats:italic toggle=\"yes\">P<\/jats:italic> \u2264 0.0001) as well as between SVR12 to 3-years follow-up (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0005). Stratified by fibrosis stage, patients with advanced fibrosis and cirrhosis showed a more pronounced and significant improvement of LS during follow-up after SVR compared to patients with less advanced fibrosis stage. During the follow-up period, 3 (5.2%) cirrhotic patients developed liver-related events, including 2 (3.4%) patients with de novo HCC and one (1.7%) patient experienced ascites for the first time.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This 3-year follow-up study provides evidence for the durability of SVR, improvement of liver function parameters and ALBI score and grade in patients with an advanced stage of fibrosis, in particular, and reduction of the clinical events after successful treatment with DAAs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/meg.0000000000002240","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T11:08:55Z","timestamp":1625656135000},"page":"e746-e752","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Long-term clinical outcomes in sustained responders with chronic hepatitis C after treatment with direct-acting antivirals"],"prefix":"10.1097","volume":"33","author":[{"given":"Shereen Abdel","family":"Alem","sequence":"first","affiliation":[{"name":"Endemic Medicine and Hepatology Department, Faculty of Medicine, Cairo University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Eletreby","sequence":"additional","affiliation":[{"name":"Endemic Medicine and Hepatology Department, Faculty of Medicine, Cairo University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Abdellatif","sequence":"additional","affiliation":[{"name":"Endemic Medicine and Hepatology Department, Faculty of Medicine, Cairo University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Ramadan","sequence":"additional","affiliation":[{"name":"Endemic Medicine and Hepatology Department, Faculty of Medicine, Cairo University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Nagy","sequence":"additional","affiliation":[{"name":"National Committee for Combating Viral Hepatitis (NCCVH), Ministry of Health, Cairo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"AbdAllah","sequence":"additional","affiliation":[{"name":"Medical Research Division, National Research Centre, Giza, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Elsharkawy","sequence":"additional","affiliation":[{"name":"Endemic Medicine and Hepatology Department, Faculty of Medicine, Cairo University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabab","family":"Fouad","sequence":"additional","affiliation":[{"name":"Endemic Medicine and Hepatology Department, Faculty of Medicine, Cairo University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal","family":"Esmat","sequence":"additional","affiliation":[{"name":"Endemic Medicine and Hepatology Department, Faculty of Medicine, Cairo University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omnia","family":"Tantawi","sequence":"additional","affiliation":[{"name":"Endemic Medicine and Hepatology Department, Faculty of Medicine, Cairo University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,7,6]]},"reference":[{"key":"R1-20240821","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1053\/j.gastro.2015.08.035","article-title":"Extrahepatic morbidity and mortality of chronic hepatitis C.","volume":"149","author":"Negro","year":"2015","journal-title":"Gastroenterology"},{"key":"R2-20240821","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.22694","article-title":"Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients.","volume":"49","author":"George","year":"2009","journal-title":"Hepatology"},{"key":"R3-20240821","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"Recommendations on treatment of hepatitis C 2018.","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"R4-20240821","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12879-015-0748-8","article-title":"Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits.","volume":"15","author":"Smith-Palmer","year":"2015","journal-title":"BMC Infect Dis"},{"key":"R5-20240821","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/j.gastro.2016.09.009","article-title":"Eradication of hepatitis C virus infection in patients with cirrhosis reduces risk of liver and non-liver complications.","volume":"152","author":"Nahon","year":"2017","journal-title":"Gastroenterology"},{"key":"R6-20240821","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.jhep.2016.07.039","article-title":"Reversion of disease manifestations after HCV eradication.","volume":"65","author":"van der Meer","year":"2016","journal-title":"J Hepatol"},{"key":"R7-20240821","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis.","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"R8-20240821","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med Biol"},{"key":"R9-20240821","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"R10-20240821","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection.","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"R11-20240821","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade.","volume":"33","author":"Johnson","year":"2015","journal-title":"J Clin Oncol"},{"key":"R12-20240821","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/liv.13256","article-title":"Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index.","volume":"37","author":"Bachofner","year":"2017","journal-title":"Liver Int"},{"issue":"Suppl 1","key":"R13-20240821","first-page":"434A","article-title":"Long-term follow-up of patients with chronic HCV infection treated with daclatasvir-based regimens in phase 2 and 3 studies.","volume":"64","author":"Reddy","year":"2016","journal-title":"Hepatology"},{"key":"R14-20240821","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/apt.13343","article-title":"Improvement of liver function parameters in advanced HCV-associated liver cirrhosis by IFN-free antiviral therapies.","volume":"42","author":"Deterding","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"R15-20240821","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1172\/JCI75938","article-title":"Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome.","volume":"124","author":"Meissner","year":"2014","journal-title":"J Clin Invest"},{"key":"R16-20240821","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1177\/2050640619840149","article-title":"Hepatitis C virus therapy in advanced liver disease: outcomes and challenges.","volume":"7","author":"Ekpanyapong","year":"2019","journal-title":"United European Gastroenterol J"},{"key":"R17-20240821","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/jvh.13408","article-title":"Impact of direct-acting antiviral agents on liver function in patients with chronic hepatitis C virus infection.","volume":"28","author":"Johnson","year":"2021","journal-title":"J Viral Hepat"},{"key":"R18-20240821","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1111\/jgh.13758","article-title":"Changes in liver stiffness measurements and fibrosis scores following sofosbuvir based treatment regimens without interferon.","volume":"32","author":"Elsharkawy","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"R19-20240821","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/jvh.13280","article-title":"Dynamics of liver stiffness by transient elastography in patients with chronic hepatitis C virus infection receiving direct-acting antiviral therapy-results from the German Hepatitis C-Registry.","volume":"27","author":"Knop","year":"2020","journal-title":"J Viral Hepat"},{"key":"R20-20240821","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/jvh.13245","article-title":"Transient elastography in DAA era. Relation between post-SVR LSM and histology.","volume":"27","author":"Mart\u00ednez-Campreci\u00f3s","year":"2020","journal-title":"J Viral Hepat"},{"key":"R21-20240821","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jhep.2016.06.019","article-title":"Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis.","volume":"65","author":"Cheung","year":"2016","journal-title":"J Hepatol"},{"key":"R22-20240821","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.cgh.2020.02.044","article-title":"Disease progression in patients with hepatitis C virus infection treated with direct-acting antiviral agents.","volume":"18","author":"Mendizabal","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R23-20240821","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2893.2008.01006.x","article-title":"Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C.","volume":"15","author":"Scherzer","year":"2008","journal-title":"J Viral Hepat"},{"key":"R24-20240821","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1478-3231.2004.0956.x","article-title":"Risk factors for hepatocellular carcinoma in Hepatitis C patients with sustained virologic response to interferon therapy.","volume":"24","author":"Iwasaki","year":"2004","journal-title":"Liver Int"},{"key":"R25-20240821","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: final update of the series.","volume":"73","author":"Pawlotsky","year":"2020","journal-title":"J Hepatol"}],"container-title":["European Journal of Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MEG.0000000000002240","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T22:01:06Z","timestamp":1724364066000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MEG.0000000000002240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,6]]},"references-count":25,"journal-issue":{"issue":"1S","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/meg.0000000000002240","relation":{},"ISSN":["0954-691X"],"issn-type":[{"value":"0954-691X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,6]]}}}